Literature DB >> 2036029

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany.

E Schöpf1, A Stühmer, B Rzany, N Victor, R Zentgraf, J F Kapp.   

Abstract

Little work has been carried out on the epidemiology of the two serious skin reactions--toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). We collected details of all the hospitalized cases of TEN and SJS in the Federal Republic of Germany for the years 1981 through 1985 inclusive. Inquiries by telephone, letter, and personal visits produced an overall response of 91%; 259 cases of TEN and 315 cases of SJS were identified. From these data, we were able to calculate an overall annual risk of 0.93 and 1.1 per million for TEN and SJS, respectively. The average age group was higher for TEN (63 years) than for SJS (25 years). Women are markedly more at risk for TEN in the ratio of 2:1, these figures being reversed for SJS. The mortality was 34% (87/259) for TEN and only 1% (2/315) for SJS. An association with previous medication defined as "definite, probable, possible" could be established for 89% of cases of TEN and 54% of cases of SJS. The drugs most commonly involved were antibiotics (TEN, 40%; SJS, 34%), followed by the analgesics (TEN, 23%; SJS, 33%). As with the drug groups, the incidences being based on the defined daily doses, were high for sulfonamides, beta-lactam antibiotics, and some nonsteroidal anti-inflammatory drugs.

Entities:  

Mesh:

Year:  1991        PMID: 2036029     DOI: 10.1001/archderm.1991.01680050083008

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  58 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 2.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

Review 3.  [Severe cutaneous adverse drug reactions. Clinical features and epidemiology ].

Authors:  M Mockenhaupt
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

Review 4.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

5.  Early pathological features of the cornea in toxic epidermal necrolysis.

Authors:  G P Williams; H S Mudhar; M Leyland
Journal:  Br J Ophthalmol       Date:  2007-03-14       Impact factor: 4.638

6.  Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study.

Authors:  Elisa Martín-Merino; Francisco J de Abajo; Miguel Gil
Journal:  Eur J Clin Pharmacol       Date:  2015-05-05       Impact factor: 2.953

7.  Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis.

Authors:  Qiancheng Deng; Xia Fang; Qinghai Zeng; Jianyun Lu; Chen Jing; Jinhua Huang
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

Review 8.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

9.  Fluconazole induced toxic epidermal necrolysis: a case report.

Authors:  Uchenna R Ofoma; Edward K Chapnick
Journal:  Cases J       Date:  2009-11-20

10.  Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case report.

Authors:  Mohamed El Ghonemi; Hesham R Omar; Rania Rashad; Jaya Kolla; Devanand Mangar; Enrico Camporesi
Journal:  Cases J       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.